Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
11.5M
-
Shares change
-
+92K
-
Total reported value, excl. options
-
$496M
-
Value change
-
-$10.5M
-
Number of buys
-
45
-
Number of sells
-
-40
-
Price
-
$43.24
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q1 2020
98 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q1 2020.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.5M shares
of 29.1M outstanding shares and own 39.43% of the company stock.
Largest 10 shareholders include FMR LLC (1.15M shares), Redmile Group, LLC (1.05M shares), BAKER BROS. ADVISORS LP (946K shares), FRAZIER MANAGEMENT LLC (895K shares), PRICE T ROWE ASSOCIATES INC /MD/ (893K shares), BlackRock Inc. (827K shares), Consonance Capital Management LP (655K shares), VANGUARD GROUP INC (638K shares), CREDIT SUISSE AG/ (580K shares), and CITADEL ADVISORS LLC (542K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.